Immuneering
IMRX
#9279
Rank
โ‚น5.28 B
Marketcap
โ‚น170.17
Share price
8.70%
Change (1 day)
-70.77%
Change (1 year)

Revenue for Immuneering (IMRX)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of โ‚น26.22 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immuneering from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A-100%
2022 โ‚น26.22 M-83.06%
2021 โ‚น0.15 B-8.42%
2020 โ‚น0.16 B